Grace Therapeutics GRCE Cash Flow Statement (2011-2026)

NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST
Reported Financials

Grace Therapeutics Quarterly Cash Flow Statement

Periods 62 quarters
Latest Sep 2026

Grace Therapeutics reported cash from operations of -$1.78M and free cash flow of -$1.78M for the quarter ended Sep 2026, up 43.2% year over year. This cash flow statement covers 62 quarters of results from May 2011 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-3.78M-3.90M-4.52M-4.93M-3.89M-29.09M-4.02M-3.27M-2.39M-3.17M-2.62M-3.43M-4.16M0.64M-3.36M-0.94M-2.32M-1.18M-15.79M-2.13M
Depreciation and DepletionDep. & Depletion
0.17M-0.06M0.01M0.01M0.01M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
Depreciation & Amortization (CF)Dep. & Amort.
0.17M-0.06M0.01M0.01M0.01M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Share-based CompensationStock Comp.
0.45M0.62M0.46M582.00443.000.32M0.08M0.28M0.33M0.23M0.24M0.20M0.16M0.13M0.30M0.21M0.11M0.18M0.11M0.20M
Deferred Taxes
-0.65M-0.24M-0.16M-0.27M-8.87M-0.29M-0.45M-0.21M-0.89M-0.72M-0.85M-0.61M-1.02M-1.70M
Gains from Sales and DivestituresGains Divest
-0.04M-0.01M0.04M0.00M0.03M0.00M
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
-0.25M0.03M28.65M0.01M0.02M-0.03M13.53M
Other non-cash itemsOther Non-Cash
-0.83M-0.24M-0.01M0.03M1.83M-0.13M1.03M-1.40M-0.36M1.18M-2.64M0.49M-1.43M0.04M
Non-cash ItemsNon-Cash Items
Change in Working Capital
-0.68M1.03M-1.27M1.13M-0.04M
Change in ReceivablesChange Receivables
0.03M0.04M0.12M-0.24M-0.33M0.02M-0.11M-0.18M-0.11M
Change in InventoryChange Inventory
Change in Account PayablesChange Payables
-0.07M-1.45M-0.54M0.40M-0.06M0.91M0.08M-0.70M-0.37M0.71M-1.07M0.04M0.86M-0.90M0.23M
Change in Accrued ExpensesChange Accrued Exp.
Change in Other Operating AssetsOther Assets Change
-0.45M0.53M-0.08M-0.23M-0.53M0.34M-0.15M0.11M-0.13M0.05M-0.08M0.10M-0.14M0.17M-0.42M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.01M-0.01M
Other Working Capital ChangesOther WC Changes
1.27M-1.41M0.45M2.03M-4.52M0.23M0.53M-0.34M0.15M-0.11M0.13M-0.05M0.08M-0.10M0.14M-0.17M0.42M
Cash from OperationsCash from Ops.
-4.58M-3.15M-5.43M-3.44M-3.72M-3.33M-6.24M-2.11M-1.89M-2.09M-3.60M-4.24M-4.12M-2.95M-1.80M-3.14M-2.23M-1.70M-3.22M-1.78M
Investing Activities
Capital ExpendituresCapex
0.01M0.00M0.01M0.02M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.15M-0.15M0.00M
Change in Property, Plant and EquipmentChange in PP&E
0.14M-0.15M-0.01M-0.02M
Change in IntangiblesChange Intangibless
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Purchase of InvestmentsInvestments Purchased
13.32M0.08M0.02M0.00M5.00M6.55M0.02M
Sale and Maturity of InvestmentsInvestments Sold
13.88M0.09M13.28M-0.10M5.00M6.57M
Change in Acquisitions & DivestmentsChange Acquisitions
-13.32M-0.08M-0.02M0.00M-5.00M-6.55M
Other Investing Activities (as filed)Other investing (as filed)
Cash from Investing ActivitiesCash from Investing
0.56M0.01M13.26M-0.10M-5.00M4.99M0.11M-6.55M6.55M-0.02M0.02M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
0.20M0.11M0.02M4.04M
Net Shares Issued and RepurchasedNet Shares Issued
0.20M0.11M0.02M4.04M
Net Equity Issued and RepurchasedNet Equity Issued
0.20M0.11M0.02M4.04M
Other financing activities (as filed)
-0.97M-0.33M-0.66M
Cash from Financing ActivitiesCash from Financing
0.20M0.11M7.36M14.03M-0.33M4.04M9.34M
Additional items
Exchange Rate EffectFX Effect
-0.03M0.26M0.05M-0.22M0.30M-0.13M0.00M0.00M
Change in Cash
-3.92M-2.67M8.04M-3.45M-8.69M1.63M-6.24M5.36M-8.45M4.46M-3.61M-4.24M-4.10M11.08M-2.13M-3.14M1.81M-1.70M-3.22M7.56M
Beginning Cash Balance
2.62M
Ending Cash Balance
33.01M30.34M38.38M26.24M26.24M27.88M21.63M26.99M18.55M23.01M19.39M15.16M11.06M22.13M20.01M16.86M18.67M16.98M13.76M16.98M
Free Cash FlowFCF
-4.58M-3.15M-5.43M-3.44M-3.72M-3.33M-6.24M-2.11M-1.89M-2.11M-3.60M-4.24M-4.12M-2.95M-1.80M-3.14M-2.23M-1.70M-3.22M-1.78M
Net Cash FlowNCF
-4.03M-3.13M8.03M-3.43M-8.72M1.67M-6.24M5.36M-8.45M4.46M-3.61M-4.24M-4.10M11.08M-2.13M-3.14M1.81M-1.70M-3.22M7.56M
Interest Paid

Grace Therapeutics Cash Flow Statement API

Pull Grace Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GRCE&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY